Biotec Pharmacon aims to increase knowledge of the company through precise and confident communication with shareholders, analysts and investors.
The company emphasizes the equal and simultaneous information to the stock market.
Biotec Pharmacon normally holds open investor presentations in connection with the submission of quarterly results.
News, performance reports and presentations are posted on the company's website www.biotec.no. Press releases are distributed as well through Hugin/Thomson Reuters.
